Application number | Title of the application | Filing Date | Status |
---|
09/462574 | NUCLEIC ACID ENCODING A NOVEL CHEMOTHERAPY-INDUCED PROTEIN, AND METHODS OF USE | Jun 4, 2000 | Abandoned |
Array
(
[id] => 4190593
[patent_doc_number] => 06130084
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-10
[patent_title] => 'Nutrition from pollution'
[patent_app_type] => 1
[patent_app_number] => 9/374966
[patent_app_country] => US
[patent_app_date] => 1999-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 2876
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/130/06130084.pdf
[firstpage_image] =>[orig_patent_app_number] => 374966
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/374966 | Nutrition from pollution | Aug 15, 1999 | Issued |
Array
(
[id] => 4177389
[patent_doc_number] => 06149905
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Tumor cells with increased immunogenicity and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/159135
[patent_app_country] => US
[patent_app_date] => 1998-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 8
[patent_no_of_words] => 18282
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/149/06149905.pdf
[firstpage_image] =>[orig_patent_app_number] => 159135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/159135 | Tumor cells with increased immunogenicity and uses therefor | Sep 22, 1998 | Issued |
Array
(
[id] => 4293170
[patent_doc_number] => 06184033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune deficiency syndrome (HIV infection)'
[patent_app_type] => 1
[patent_app_number] => 9/156258
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 19
[patent_no_of_words] => 19044
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184033.pdf
[firstpage_image] =>[orig_patent_app_number] => 156258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/156258 | Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune deficiency syndrome (HIV infection) | Sep 17, 1998 | Issued |
Array
(
[id] => 4077009
[patent_doc_number] => 06054116
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Chimeric mouse for human and mouse immune systems'
[patent_app_type] => 1
[patent_app_number] => 9/115424
[patent_app_country] => US
[patent_app_date] => 1998-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 5150
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054116.pdf
[firstpage_image] =>[orig_patent_app_number] => 115424
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/115424 | Chimeric mouse for human and mouse immune systems | Jul 14, 1998 | Issued |
Array
(
[id] => 4150912
[patent_doc_number] => 06124104
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'Chromosome 13-linked breast cancer susceptibility gene'
[patent_app_type] => 1
[patent_app_number] => 9/044908
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 51438
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124104.pdf
[firstpage_image] =>[orig_patent_app_number] => 044908
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/044908 | Chromosome 13-linked breast cancer susceptibility gene | Mar 19, 1998 | Issued |
Array
(
[id] => 4128506
[patent_doc_number] => 06033857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Chromosome 13-linked breast cancer susceptibility gene'
[patent_app_type] => 1
[patent_app_number] => 9/044946
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 51442
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/033/06033857.pdf
[firstpage_image] =>[orig_patent_app_number] => 044946
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/044946 | Chromosome 13-linked breast cancer susceptibility gene | Mar 19, 1998 | Issued |
Array
(
[id] => 4108977
[patent_doc_number] => 06057300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Methods for treating cancers and restenosis with p21'
[patent_app_type] => 1
[patent_app_number] => 9/031572
[patent_app_country] => US
[patent_app_date] => 1998-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6020
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/057/06057300.pdf
[firstpage_image] =>[orig_patent_app_number] => 031572
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/031572 | Methods for treating cancers and restenosis with p21 | Feb 25, 1998 | Issued |
Array
(
[id] => 4089809
[patent_doc_number] => 06096305
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Receptor that binds IL-17'
[patent_app_type] => 1
[patent_app_number] => 9/022253
[patent_app_country] => US
[patent_app_date] => 1998-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18105
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096305.pdf
[firstpage_image] =>[orig_patent_app_number] => 022253
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/022253 | Receptor that binds IL-17 | Feb 10, 1998 | Issued |
Array
(
[id] => 4220474
[patent_doc_number] => 06087556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Transgenic animals capable of replicating hepatitis viruses and mimicking chronic hepatitis infection in humans'
[patent_app_type] => 1
[patent_app_number] => 9/003200
[patent_app_country] => US
[patent_app_date] => 1998-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4944
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087556.pdf
[firstpage_image] =>[orig_patent_app_number] => 003200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/003200 | Transgenic animals capable of replicating hepatitis viruses and mimicking chronic hepatitis infection in humans | Jan 6, 1998 | Issued |
Array
(
[id] => 4151149
[patent_doc_number] => 06156307
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Immortalization of dendritic cells with v-myc oncogene'
[patent_app_type] => 1
[patent_app_number] => 9/002380
[patent_app_country] => US
[patent_app_date] => 1998-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 18
[patent_no_of_words] => 8077
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156307.pdf
[firstpage_image] =>[orig_patent_app_number] => 002380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/002380 | Immortalization of dendritic cells with v-myc oncogene | Jan 1, 1998 | Issued |
Array
(
[id] => 4118421
[patent_doc_number] => 06071893
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Interleukin-12 as an adjuvant for paramyxoviridae vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/980160
[patent_app_country] => US
[patent_app_date] => 1997-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6439
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071893.pdf
[firstpage_image] =>[orig_patent_app_number] => 980160
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/980160 | Interleukin-12 as an adjuvant for paramyxoviridae vaccines | Nov 25, 1997 | Issued |
Array
(
[id] => 4182294
[patent_doc_number] => 06037520
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing'
[patent_app_type] => 1
[patent_app_number] => 8/958167
[patent_app_country] => US
[patent_app_date] => 1997-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2710
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037520.pdf
[firstpage_image] =>[orig_patent_app_number] => 958167
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/958167 | Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing | Oct 26, 1997 | Issued |
Array
(
[id] => 4171275
[patent_doc_number] => 06083719
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis'
[patent_app_type] => 1
[patent_app_number] => 8/968768
[patent_app_country] => US
[patent_app_date] => 1997-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8944
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083719.pdf
[firstpage_image] =>[orig_patent_app_number] => 968768
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/968768 | Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis | Oct 26, 1997 | Issued |
Array
(
[id] => 4240499
[patent_doc_number] => 06136306
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Method for treating tumors'
[patent_app_type] => 1
[patent_app_number] => 8/943953
[patent_app_country] => US
[patent_app_date] => 1997-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6488
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136306.pdf
[firstpage_image] =>[orig_patent_app_number] => 943953
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/943953 | Method for treating tumors | Oct 2, 1997 | Issued |
Array
(
[id] => 4140940
[patent_doc_number] => 06063359
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'Method for determining oncogenic activity of a substance'
[patent_app_type] => 1
[patent_app_number] => 8/938295
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9535
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063359.pdf
[firstpage_image] =>[orig_patent_app_number] => 938295
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938295 | Method for determining oncogenic activity of a substance | Sep 25, 1997 | Issued |
08/849120 | TISSUE- SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS | Sep 16, 1997 | Abandoned |
08/931031 | COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES | Sep 15, 1997 | Abandoned |
Array
(
[id] => 4126532
[patent_doc_number] => 06127332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Muteins of IFN-.beta.'
[patent_app_type] => 1
[patent_app_number] => 8/912768
[patent_app_country] => US
[patent_app_date] => 1997-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 9510
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127332.pdf
[firstpage_image] =>[orig_patent_app_number] => 912768
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/912768 | Muteins of IFN-.beta. | Aug 17, 1997 | Issued |
Array
(
[id] => 4288068
[patent_doc_number] => 06211160
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Method for tolerizing a mammalian patient to administration of gene therapy virus vectors'
[patent_app_type] => 1
[patent_app_number] => 8/889930
[patent_app_country] => US
[patent_app_date] => 1997-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 11
[patent_no_of_words] => 4795
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211160.pdf
[firstpage_image] =>[orig_patent_app_number] => 889930
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/889930 | Method for tolerizing a mammalian patient to administration of gene therapy virus vectors | Jul 9, 1997 | Issued |